Trial of VLTS-589 in Subjects With Intermittent Claudication
Public ClinicalTrials.gov record NCT00068133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Multicenter, Double-Blind, Placebo-Controlled, Trial of VLTS-589 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Study identification
- NCT ID
- NCT00068133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Valentis
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Interventions
- Plasmid based Gene Transfer product-VLTS-589 Genetic
Genetic
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2003
- Primary completion
- Not listed
- Completion
- May 31, 2005
- Last update posted
- Jun 23, 2005
2003 – 2005
United States locations
- U.S. sites
- 20
- U.S. states
- 18
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology Pc | Birmingham | Alabama | 35211 | — |
| Arizona Heart Institute | Phoenix | Arizona | 85016 | — |
| Access Clinical Trials-Cardiovascular Research | Beverly Hills | California | 90210 | — |
| Jacksonville Heart Center | Jacksonville | Florida | 32207 | — |
| Heart Specialists of Sarasota Clinical Research Center | Sarasota | Florida | 34239 | — |
| American Cardiovascular Research Institute | Atlanta | Georgia | 30342 | — |
| Rush Presbyterian St. Luke's Medical Center | Chicago | Illinois | 60612 | — |
| Prairie Heart Institution at St. John's Hospital | Springfield | Illinois | 62701 | — |
| The Care Group | Indianapolis | Indiana | 46260 | — |
| New Orleans Center for Clinical Research | New Orleans | Louisiana | 70119 | — |
| Androscoggin Cardiology Associates | Auburn | Maine | 04210 | — |
| University of Michigan Health Systems | Ann Arbor | Michigan | 48109 | — |
| Minneapolis Heart Institution Foundation | Minneapolis | Minnesota | 55407 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| St. Vincent's Hospital | New York | New York | 10011 | — |
| Duke Clinical Research Institute | Durham | North Carolina | 27715 | — |
| University of Oklahoma Health Science Center | Oklahoma City | Oklahoma | 73104 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| The Methodist Hospital | Houston | Texas | 77030 | — |
| Daniel Gottleib, MD | Seattle | Washington | 98166 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00068133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00068133 live on ClinicalTrials.gov.